← SynDRA
EBVACICLIB
SynDRA canonical compound SYN0039875 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CDK2 | CDK4 | CDK6 |
|---|
| Mechanism of action | CDK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
Cross-references
Synonyms
- PF-06873600
- QIEKHLDZKRQLLN-FOIQADDNSA-N
- SCHEMBL19857421
- HY-114177
- CS-0078633
- PF 06873600
- Ebvaciclib [USAN]
- 3B512HJD65
- EBVACICLIB [INN]
- UNII-3B512HJD65
- PF06873600
- Ebvaciclib (USAN)
- RefChem:136191
- CDK Inhibitor PF-06873600
- C20H27F2N5O4S
- Ebvaciclib [WHO-DD]
- orb1298913
- SCHEMBL29359734
- GTPL10426
- BDBM370121
- GLXC-20624
- EX-A3695
- US10233188, Example 10
- MFCD31807623
- NSC812927
- WHO 11513
- AKOS040759406
- NSC-812927
- example 10 [WO2018033815]
- AC-36513
- AS-79802
- DA-66626
- T8463
- D11905
- PF-06873600?
- P200600
- Ebvaciclib; PF-06873600; PF 06873600; PF06873600
- WG1
Look up EBVACICLIB in the interactive SynDRA portal →